Mr. Carlos Ponce reports

LUMIERA BEGINS FISCAL YEAR STRONG WITH +25% GROWTH IN Q1 2022 COMPARED TO PREVIOUS YEAR

Lumiera Health Inc.'s corporate strategy and plans that were put place in 2021 are continuing to prove successful with Lumiera's fiscal Q1 2022 being another strong quarter, with sales greater than 25 per cent versus Q1 2021.

The increase in the company's sales has been driven by the new sales and in-store training team deployed late last year. The team is helping build distribution and training key in-store influencers on the benefits of Lumiera's products. In addition, Lumiera is continuing to build on-line sales with e-retailers such as Amazon, and Lumiera's own Holizen and Awaye websites.

"Following the launch of the new corporate strategy developed in the first half of 2021, I'm very pleased to say that the growth we began to experience in Q3 2021 led to record sales in Q4 2021, and another strong quarter in Q1 2022. Based on our success, we are increasing our investment in inventory to enable us to capitalize on additional growth opportunities. From a profitability perspective, we are particularly excited by the fact that our growth is also leading to increased margins," says Carlos Ponce, chief executive officer of Lumiera. "Moving forward, we are laser-focused on increasing our retail and on-line distribution; based on the positive feedback we have from people that have tried our Bazzzics sleep aids and Awaye pain relief cream, we know that distribution expansion leads to accelerated sales growth and we expect revenues to increase exponentially."

Management will continue executing its plan for growth and expects to see the upward sales trends continue for the foreseeable future.

Audited financial statements will be released on or before March 31, 2022.

About Lumiera Health Inc.

Lumiera specializes in the development and commercialization of consumer products for the natural health industry. The company sells herbal tonics and natural supplements through its Holizen Laboratories division, with a diverse portfolio including a line of innovative sleep aids. The company is also developing and commercializing a unique range of products acting on the endocannabinoid system, and offering novel solutions for the treatment of acute and chronic pain. A pioneer in the natural health innovation space, the Lumiera brand is rooted in the core values of science, nature and compassion. The company's goal is to make people's lives better by developing natural health and wellness products that are effective, safe and trustworthy.

We seek Safe Harbor.